133 related articles for article (PubMed ID: 25030393)
1. Fluorocholine PET/computed tomography: physiologic uptake, benign findings, and pitfalls.
Beheshti M; Haroon A; Bomanji JB; Langsteger W
PET Clin; 2014 Jul; 9(3):299-306. PubMed ID: 25030393
[TBL] [Abstract][Full Text] [Related]
2. Proliferation imaging with ¹⁸F-fluorothymidine PET/computed tomography: physiologic uptake, variants, and pitfalls.
Herrmann K; Buck AK
PET Clin; 2014 Jul; 9(3):331-8. PubMed ID: 25030396
[TBL] [Abstract][Full Text] [Related]
3. ¹¹C-acetate PET/CT imaging: physiologic uptake, variants, and pitfalls.
Karanikas G; Beheshti M
PET Clin; 2014 Jul; 9(3):339-44. PubMed ID: 25030397
[TBL] [Abstract][Full Text] [Related]
4. ¹⁸F-DOPA PET/computed tomography imaging.
Chondrogiannis S; Marzola MC; Rubello D
PET Clin; 2014 Jul; 9(3):307-21. PubMed ID: 25030394
[TBL] [Abstract][Full Text] [Related]
5. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
6. Incidental detection of Hürthle cell adenoma by 18F-choline PET/CT scan in a patient with prostate cancer.
Paone G; Treglia G; Bongiovanni M; Ruberto T; Ceriani L; Giovanella L
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):340-1. PubMed ID: 23796426
[No Abstract] [Full Text] [Related]
7. [The PET/CT with 18F-fluorocholine in the diagnosis of gliomatosis cerebri type 2].
Niccoli-Asabella A; Notaristefano A; Garribba MG; Rubini D; Ferrari C; Rubini G
Recenti Prog Med; 2013 Feb; 104(2):73-5. PubMed ID: 23535962
[TBL] [Abstract][Full Text] [Related]
8. [Pitfalls with 18F-choline PET/CT in patients with prostate cancer].
García Vicente AM; Núñez García A; Soriano Castrejón AM; Jiménez Londoño GA; Cordero García JM; Palomar Muñoz A
Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):37-9. PubMed ID: 23177342
[TBL] [Abstract][Full Text] [Related]
9. Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
BJU Int; 2012 Nov; 110(10):1501-6. PubMed ID: 22502982
[TBL] [Abstract][Full Text] [Related]
10. FDG uptake in brown adipose tissue-a brief report on brown fat with FDG uptake mechanisms and quantitative analysis using dual-time-point FDG PET/CT.
Esen Akkas B; Gökaslan D; Güner L; Ilgin Karabacak N
Rev Esp Med Nucl; 2011; 30(1):14-8. PubMed ID: 20702004
[TBL] [Abstract][Full Text] [Related]
11. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake.
Kostakoglu L; Hardoff R; Mirtcheva R; Goldsmith SJ
Radiographics; 2004; 24(5):1411-31. PubMed ID: 15371617
[TBL] [Abstract][Full Text] [Related]
12. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
[TBL] [Abstract][Full Text] [Related]
13. Abdomen: normal variations and benign conditions resulting in uptake on FDG-PET/CT.
Zukotynski K; Kim CK
PET Clin; 2014 Apr; 9(2):169-83. PubMed ID: 25030280
[TBL] [Abstract][Full Text] [Related]
14. Incidental possible diagnosis by 18F-fluorocholine PET/CT of Meckel's diverticulum and potential pitfalls.
Khor LK; Loi HY; Sinha AK; Lu SJ
Hell J Nucl Med; 2015; 18(2):157-9. PubMed ID: 26187217
[TBL] [Abstract][Full Text] [Related]
15. Cancer imaging with fluorine-18-labeled choline derivatives.
Kwee SA; DeGrado TR; Talbot JN; Gutman F; Coel MN
Semin Nucl Med; 2007 Nov; 37(6):420-8. PubMed ID: 17920349
[TBL] [Abstract][Full Text] [Related]
16. Thorax: normal and benign pathologic patterns in FDG-PET/CT imaging.
Wachsmann JW; Gerbaudo VH
PET Clin; 2014 Apr; 9(2):147-68. PubMed ID: 25030279
[TBL] [Abstract][Full Text] [Related]
17. Iodinated Choline Transport-Targeted Tracers.
Švec P; Nový Z; Kučka J; Petřík M; Sedláček O; Kuchař M; Lišková B; Medvedíková M; Kolouchová K; Groborz O; Loukotová L; Konefał RŁ; Hajdúch M; Hrubý M
J Med Chem; 2020 Dec; 63(24):15960-15978. PubMed ID: 33271015
[TBL] [Abstract][Full Text] [Related]
18. FDG PET/CT in patients with HIV.
Davison JM; Subramaniam RM; Surasi DS; Cooley T; Mercier G; Peller PJ
AJR Am J Roentgenol; 2011 Aug; 197(2):284-94. PubMed ID: 21785073
[TBL] [Abstract][Full Text] [Related]
19. Promising role of [18F] fluorocholine PET/CT vs [18F] fluorodeoxyglucose PET/CT in primary brain tumors-early experience.
Lam WW; Ng DC; Wong WY; Ong SC; Yu SW; See SJ
Clin Neurol Neurosurg; 2011 Feb; 113(2):156-61. PubMed ID: 21036467
[TBL] [Abstract][Full Text] [Related]
20. Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions.
Shammas A; Lim R; Charron M
Radiographics; 2009; 29(5):1467-86. PubMed ID: 19755606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
